The effect of recombinant α-interferon on natural killer cell activity and clinical course in patients with myelodysplastic syndrome

Xenophon Yataganas, P Fessas, John Meletis(Athens State University), G. Vayopoulos(National and Kapodistrian University of Athens), Nora Viniou(National and Kapodistrian University of Athens), George D. Eliopoulos(University of Crete), Stavroula A. Koulocheri(National and Kapodistrian University of Athens), E. Plata(National and Kapodistrian University of Athens), Panagiotis Panagiotidis(National and Kapodistrian University of Athens)
Annals of Hematology
June 1, 1991
10.1007/bf01729837
Cited by 3

Related Papers

Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2
|Nature Genetics|2003|389
Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti–tumor necrosis factor-α antibody therapy
|Blood|2002|266
Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis
|Annals of the Rheumatic Diseases|2007|154
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
|Blood|2015|154
Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha–mediated effect
|Blood|2002|138